The monoglutamate form can stimulate glioma cell proliferation by activating MAPK and PI3K/AKT pathways (Schneider and Ryan, 2006; Oleinik et al., 2014; Robert and Sontheimer, 2014). This evidence concerns the gene PIK3CA and central nervous system cancer.